Resveratrol modulates TME-triggered inflammation, EMT, invasion, and TME-suppressed apoptosis and acts synergistically with NF-κB-ASO in CRC cells but not by knockdown of β1-integrin in CRC cells. The gene discussed is NFKB1; the disease is colorectal carcinoma.